Hyperinflation Respiratory Therapies in Cardiac Surgery Patients

Description

The purpose of this prospective randomized clinical trial is to evaluate three different types of hyperinflation respiratory therapies, Intermittent Positive Pressure Breathing (IPPB), Intermittent positive end expiratory pressure (EzPAP), Metaneb. Investigators will examine which hyperinflation therapy provides better lung expansion and may improve lung recovery after surgery.

Conditions

Pulmonary Disease, Postoperative Complications

Study Overview

Study Details

Study overview

The purpose of this prospective randomized clinical trial is to evaluate three different types of hyperinflation respiratory therapies, Intermittent Positive Pressure Breathing (IPPB), Intermittent positive end expiratory pressure (EzPAP), Metaneb. Investigators will examine which hyperinflation therapy provides better lung expansion and may improve lung recovery after surgery.

Hyperinflation Respiratory Therapies in Cardiac Surgery Patients: a Randomized, Observer-Blinded, Prospective Clinical Trial

Hyperinflation Respiratory Therapies in Cardiac Surgery Patients

Condition
Pulmonary Disease
Intervention / Treatment

-

Contacts and Locations

Dallas

UT Southwestern Clements University Hospital, Dallas, Texas, United States, 75390

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Age 18 years and older
  • 2. Admitted to Cardiovascular ICU (CVICU) after coronary artery bypass grafting (CABG), isolated valve repair/replacement, or CABG + valve repair/replacement
  • 3. Cardiac surgery performed via median sternotomy
  • 1. BMI\>40
  • 2. Refusal to be consented
  • 3. Prior or current lung transplant patients

Ages Eligible for Study

18 Years to 80 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Texas Southwestern Medical Center,

Jaffer Odeh, MD, STUDY_CHAIR, UT Southwestern Medical Center

Study Record Dates

2027-12-31